Sankha Bhattacharya

Prof. Dr. Sankha Bhattacharya

SVKM's Narsee Monjee Institute of Management Studies, Shirpur., Dhule, India
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2021
Verified
Book Chapter
Open access
PDF file
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
The central composite design is the most commonly used fractional factorial design used in the response surface model. In this design, the center points are augmented with a group of axial points called star points. With this design, quickly first-order and second-order terms can be estimated. In this book chapter, different types of central composite design and their significance in various experimental design were clearly explained. Nevertheless, a calculation based on alpha (α) determination and axial points were clearly described. This book chapter also amalgamates recently incepted central composite design models in various experimental conditions. Finally, one case study was also discussed to understand the actual inside of the central composite design.

26 August 2019 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
KPKrishna Kumar Patel
Krishna Kumar Patel
DDDeepa Dehari
Deepa Dehari
AAAshish Kumar Agrawal
Ashish Kumar Agrawal
SSSanjay Singh
Sanjay Singh

13 March 2023 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
BPBhuphendra G. Prajapati
Bhuphendra G. Prajapati
SSSudarshan Singh
Sudarshan Singh

4 March 2022 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
KTKartik Tiwari
Kartik Tiwari
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
Nanosponges are nanosized drug carriers with a three-dimensional structure created by crosslinking polymers. They have the advantage of being able to hold a wide range of drugs of various sizes. Nanosponges come in a variety of shapes and sizes. They are distinguished by the research method used, the type of polymer used, and the type of drug they may contain. Nanosponges are superior to other delivery systems because they can provide a controlled drug release pattern with targeted drug delivery. The period of action, as well as the drug’s residence time, may be regulated. Since it is made of biodegradable materials, it has a low toxicity and is safe to use. The efficiency of drug encapsulation is determined by the size of the drug molecule and the amount of void space available. Cancer, enzyme and biocatalyst carrier, oxygen delivery, solubility enhancement, enzyme immobilization, and poison absorbent are some of the applications for nanosponges. The method of preparation, characterization, factors affecting nanosponge development, drug loading and release mechanism, recent developments in this area, and patents filed in the area of nanosponges are all highlighted in this study.

14 November 2023 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
Rakesh SahuRakesh Sahu
Rakesh Sahu
KSKamal Shah
Kamal Shah
RMRishabh Malviya
Rishabh Malviya
DPDeepika Paliwal
Deepika Paliwal
SSSakshi Sagar
Sakshi Sagar
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
The potential cancer risk associated with electronic-cigarette (e-cigarette) use is ongoing and remains a subject of debate. E-Cigarettes work by heating a liquid that usually contains nicotine, flavorings, and other chemicals. When the liquid is heated, users inhale an aerosol into their lungs. While e-cigarettes are generally considered less harmful than traditional tobacco products, they still contain potentially harmful chemicals, which can damage DNA and lead to cancer. Several studies have investigated the potential cancer risk associated with e-cigarette use, while other studies have suggested that e-cigarette aerosol may contain carcinogenic chemicals that could increase the risk of lung and bladder cancer in humans. However, these studies are limited in their scope and do not provide conclusive evidence. Overall, the long-term cancer risk associated with e-cigarette use remains uncertain, more research is needed to fully understand the potential risks and benefits of e-cigarettes. However, this review will allow the investigator to get more recent updates about e-cigarettes.

1 January 2024 in Advances in Polymer Technology
Verified
Journal Article
Open access
STSiddhi Throat
Siddhi Throat
Sankha BhattacharyaSankha Bhattacharya
Sankha Bhattacharya
Poly(N‐isopropylacrylamide) (PNIPAM) is a versatile polymer known for its phase transition properties, exhibiting a lower critical solution temperature (LCST) of approximately 32°C. Below this temperature, PNIPAM is hydrophilic, while above it, the polymer becomes hydrophobic, making it ideal for thermosensitive drug delivery systems (DDSs). In tissue engineering, PNIPAM provides a biocompatible, nontoxic and stimuli‐responsive surface for cell culture. Its nontoxic nature ensures safety in medical applications. PNIPAM enhances biosensing diagnostics through its affinity for biomolecules, improving accuracy. Widely used in hydrogels, smart textiles, soft robotics and various medical applications, PNIPAM adapts to environmental changes. Its straightforward synthesis allows for the creation of diverse copolymers and composites, applicable in selective reactions and conjugations with fluorescent tags or chemical modifications. PNIPAM’s versatility extends to pH‐responsive alternatives, broadening its application spectrum. Practical examples include phase separation in water treatment and cleaning processes. This discussion explores PNIPAM’s biomedical and drug delivery applications, particularly in cancer treatment, photothermal therapy (PTT) and photodynamic therapy (PDT), gene delivery and medical imaging. Additionally, it highlights PNIPAM’s noncancerous applications, such as small interfering RNA (siRNA) targeting of oncogenes and detailed imaging of deep and tumour tissues.